Carisma Therapeutics Net Income

Carisma Therapeutics (CARM) currently reports a net income of $8M as of September 2025. That compares with $-64M in the prior-year period — up 112.6% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Carisma Therapeutics's net income history and peer comparisons.

Carisma Therapeutics's net income increased from $-64M to $8M — a 112.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics's net income of $8M is lower than the Healthcare sector average of $16B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Carisma Therapeutics reported $8M in net income as of September 2025. That compares with $-64M in the prior-year period — up 112.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $8M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.